C4 Therapeutics
CCCC
CCCC
75 hedge funds and large institutions have $743M invested in C4 Therapeutics in 2020 Q4 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$105M | |
| 2 | +$80M | |
| 3 | +$68.7M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$54.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$49.4M |
Top Sellers
No sellers this quarter